FDA & Health

Working Group

FDA & Health

From food to pharmaceuticals to medical devices, the safety of what is introduced into our bodies is one of our nation’s greatest concerns. The justified importance of food and drug safety to the consumer has led to a vast regulatory framework aimed at protecting Americans from danger, but these regulations often come with a price. What are the benefits and costs of this regulatory system and how can potential improvements better ensure safety while maximizing innovation?

Featured Experts:

Michael F. Cannon
Gregory Conko
Yevgeniy Feyman
Ryan Hagemann
David A. Hyman (Chair)
Roger D. Klein
Erika Lietzan
Marisa Maleck
Henry I. Miller
Christina Sandefur
Jeff Stier
The views and opinions expressed are those of the members of the Working Groups in their personal capacities and not in their official capacities